A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food - Trial NCT06415045
Access comprehensive clinical trial information for NCT06415045 through Pure Global AI's free database. This Phase 1 trial is sponsored by Boehringer Ingelheim and is currently Not yet recruiting. The study focuses on Healthy. Target enrollment is 18 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Boehringer Ingelheim
Timeline & Enrollment
Phase 1
May 28, 2024
Jul 24, 2024
Primary Outcome
Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point (AUC 0-tz ),Maximum measured concentration of the analyte in plasma (Cmax)
Summary
The main objective is to investigate the effect of food on the pharmacokinetics of BI 1015550
 Formulation C2.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06415045
Non-Device Trial